Search Contract Opportunities

Reagents for sequencing in MiSeq and MiniSeq platforms

ID: VEID260013 • Type: Special Notice • Match:  85%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Loading

Description

PERFORMANCE WORK STATEMENT

  1. SCOPE

The laboratory of the Virology Department of the U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) is looking to purchase reagents to prepare libraries using human samples that later will be sequenced in the MiSeq and MiniSeq platforms developed by Illumina, as part of the projects of next-generation sequencing (NGS) that are being conducted at this command.

    1. BACKGROUND

The kits must be designed for library preparation and sequencing. The library preparation kit should include a variety of steps that include enzymatic fragmentation, size selection, end-repair, a-tail and ligation step in the same reaction. The process should allow including dual index at the 5 and 3 prime ends for later sample identification. Also, the library preparation kit should be designed to construct libraries with a low DNA input (~50ng) with master-mixed reagents ready to use. Similarly, the sequencing kit should allow us to run more than 150 sequencing cycles. Those cycles are needed to run paired-end libraries with a high-quality performance. We expect to have more than 2.0Gb per sequencing run with high Q30 values. Finally, the sequencing kit should include an internal control to validate the sequencing run.

  1. REQUIREMENTS
    1. Location of work / Place of delivery

Shipment to NAMRU SOUTH Callao, Peru

    1. Period of performance / Delivery time

In accordance with deliverables schedule.

    1. Deliverables schedule (if applicable)

Materials should be shipped upon award signature.

    1. Hazardous material category.

None of the items are hazardous materials.

List of products

FC-110-3001 PhiX control v3 kit

MS-102-3003 MiSeq Reagent Kit v3 (600-cycle)

FC-131-1096 Nextera XT DNA Sample Preparation Kit

FC-131-2001 Nextera XT Index Kit v2 Set A (96 indexes, 384 samples)

FC-420-1003 MiniSeq High Output Reagent Kit (300-cycles)

FC-131-2002 Nextera XT Index Kit v2 Set B (96 indexes, 384 samples)

Applicable Standards

These reagents are very time-sensitive and have limited expiration dates, reason for which, vendor should inform final users of expiration dates as soon as they become available and request their approval prior to shipment.

Special Requirements

All materials require cold chain.

Overview

Response Deadline
July 29, 2026, 1:00 a.m. EDT Due in 14 Days
Posted
July 14, 2026, 2:44 p.m. EDT
Set Aside
8(a) Sole Source (8AN)
Place of Performance
CALLAO, PE-CAL Peru
Source

Current SBA Size Standard
250 Employees
Est. Value Range
Experimental
$8,000 - $18,000 (AI estimate)
Signs of Shaping
100% of obligations for similar contracts within the Department of the Navy were awarded full & open.
On 7/14/26 Bureau of Medicine and Surgery issued Special Notice VEID260013 for Reagents for sequencing in MiSeq and MiniSeq platforms due 7/29/26.
Primary Contact
Name
Luciana Encinas   Profile
Phone
(511) 614-4141

Secondary Contact

Name
Shamai Carter   Profile
Phone
None

Documents

Posted documents for Special Notice VEID260013

Opportunity Assistant


AI Analysis

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice VEID260013

Similar Active Opportunities

Open contract opportunities similar to Special Notice VEID260013

Experts for Reagents for sequencing in MiSeq and MiniSeq platforms

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEPT OF THE NAVY > NAVSUP > NAVSUP OTHER HCA > BUMED > NAVY MEDICINE WEST
FPDS Organization Code
1700-N32398
Source Organization Code
500018734
Last Updated
July 14, 2026
Last Updated By
luciana.i.encinas.ln@health.mil
Archive Date
Aug. 13, 2026